Literature DB >> 23722268

Increasing hepatitis C prevalence and associated risk behaviors among incarcerated young adults.

Blair C McNamara1, Phyllis T Losikoff, Linda Huguenin, Grace E Macalino, Josiah D Rich, Stephen H Gregory.   

Abstract

This study sought to assess the rate of hepatitis C virus (HCV) infection and associated risk factors in young adults 18-28 years of age who were incarcerated in the Rhode Island Department of Corrections. The majority of participants reported injection drug use and engaged in high-risk behaviors such as needle sharing. Despite having these risk factors and believing themselves to be at risk, the majority of youths reported no prior HCV testing. Correctional facilities present a unique opportunity to detect HCV infection and provide risk reduction education to young adults, the population with the highest rates of new infections in the US. Seventy-two incarcerated individuals with a history of drug use were approached to participate in the study; 68 completed the screening and interview. The rate of HCV infection among adults <30 years of age and incarcerated at the Rhode Island Department of Corrections in 2011 was high (24%). In 1998, the rate of HCV among inmates <30 years of age at the same facility was only 11.4%. These data follow the same increase in HCV infection rates among young adults observed in non-incarcerated young adults across the nation. HCV is the leading cause of liver failure and hepatocellular carcinoma in the US. Despite a decline and leveling in HCV incidence nationwide, alarming increases in HCV rates among adolescents and young adults have been reported during the period between the years 1992 and 2005. This disquieting epidemic is attributable to injection drug use amongst young adults.

Entities:  

Mesh:

Year:  2014        PMID: 23722268      PMCID: PMC3978152          DOI: 10.1007/s11524-013-9807-x

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  15 in total

Review 1.  The importance of social networks in their association to drug equipment sharing among injection drug users: a review.

Authors:  Prithwish De; Joseph Cox; Jean-François Boivin; Robert W Platt; Ann M Jolly
Journal:  Addiction       Date:  2007-11       Impact factor: 6.526

Review 2.  Drug prohibition and public health: 25 years of evidence.

Authors:  E Drucker
Journal:  Public Health Rep       Date:  1999 Jan-Feb       Impact factor: 2.792

3.  Community incidence of hepatitis B and C among reincarcerated women.

Authors:  Grace E Macalino; David Vlahov; Brian P Dickinson; Beth Schwartzapfel; Josiah D Rich
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

4.  Opportunities to address the hepatitis C epidemic in the correctional setting.

Authors:  Amy E Boutwell; Scott A Allen; Josiah D Rich
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

5.  Screening for HCV infection in jails.

Authors:  Anne C Spaulding; David L Thomas
Journal:  JAMA       Date:  2012-03-28       Impact factor: 56.272

6.  Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-05-06       Impact factor: 17.586

7.  Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

Authors:  Joseph J Amon; Richard S Garfein; Linda Ahdieh-Grant; Gregory L Armstrong; Lawrence J Ouellet; Mary H Latka; David Vlahov; Steffanie A Strathdee; Sharon M Hudson; Peter Kerndt; Don Des Jarlais; Ian T Williams
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 8.  Viral hepatitis in incarcerated adults: a medical and public health concern.

Authors:  Douglas R Hunt; Sammy Saab
Journal:  Am J Gastroenterol       Date:  2009-02-24       Impact factor: 10.864

9.  Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.

Authors:  R S Garfein; M C Doherty; E R Monterroso; D L Thomas; K E Nelson; D Vlahov
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

10.  Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention.

Authors:  Timothy P Flanigan; Nickolas Zaller; Curt G Beckwith; Lauri B Bazerman; Aadia Rana; Adrian Gardner; David A Wohl; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

View more
  6 in total

1.  A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.

Authors:  John T Nguyen; Josiah D Rich; Bradley W Brockmann; Fred Vohr; Anne Spaulding; Brian T Montague
Journal:  J Urban Health       Date:  2015-08       Impact factor: 3.671

2.  Hepatitis C surveillance among youth and young adults in New York City, 2009-2013.

Authors:  Catharine Prussing; Katherine Bornschlegel; Sharon Balter
Journal:  J Urban Health       Date:  2015-04       Impact factor: 3.671

Review 3.  Will there be a vaccine to prevent HCV infection?

Authors:  Jonathan R Honegger; Yan Zhou; Christopher M Walker
Journal:  Semin Liver Dis       Date:  2014-04-29       Impact factor: 6.115

4.  Comparison of risk-based hepatitis C screening and the true seroprevalence in an urban prison system.

Authors:  Danica E Kuncio; E Claire Newbern; Marcelo H Fernandez-Viña; Bruce Herdman; Caroline C Johnson; Kendra M Viner
Journal:  J Urban Health       Date:  2015-04       Impact factor: 3.671

5.  Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Niloofar Darvishi; Mahvan Hemmati; Shamarina Shohaimi; Yasaman Ghyasi; Farahnaz Hossaini; Mohammad-Rafi Bazrafshan; Hakimeh Akbari; Masoud Mohammadi
Journal:  Arch Virol       Date:  2022-02-14       Impact factor: 2.574

6.  Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014.

Authors:  Lauren J Stockman; James Greer; Ryan Holzmacher; Beth Dittmann; Scott A Hoftiezer; Lori E Alsum; Audrey Prieve; Ryan P Westergaard; Sheila M Guilfoyle; James M Vergeront
Journal:  Public Health Rep       Date:  2016 Jul-Aug       Impact factor: 2.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.